* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Angel Sze
Company Secretary
Hong Kong, Hong Kong
8/10/2022
This Form 13F does not include the Section 13(f) securities held by Hauck & Aufhaeuser Fund Services S.A. as it determines that it exercises no investment discretion over such Section 13(f) securities as of June 30, 2022.
Other Included Managers (3):
Num
Name
File Number
1
Fidelidade-Companhia de Seguros, S.A.
028-16288
2
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
028-18303
3
AMERITRUST GROUP, INC.
028-20162
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.